劉 恆維

Medicine & Life Sciences

1. 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 100%
2. Temozolomide 62%
3. STAT3 Transcription Factor 60%
4. Exosomes 59%
5. Learning Curve 58%
6. Fluoroscopy 55%
7. Glioblastoma 49%
8. Minimally Invasive Surgical Procedures 40%
9. Case-Control Studies 40%
10. Spine 38%
11. Down-Regulation 35%
12. Macrophages 35%
13. Pedicle Screws 20%
14. Robotics 16%
15. Apoptosis Regulatory Proteins 14%
16. Tumor Microenvironment 13%
17. Carcinogenesis 12%
18. Learning 12%
19. Spondylolisthesis 10%
20. Demography 10%
21. Workflow 9%
22. Scoliosis 9%
23. Operative Time 8%
24. Cytokines 7%
25. Intraoperative Complications 7%
26. Heterografts 7%
27. Postoperative Pain 7%
28. Incidence 7%
29. Theoretical Models 6%
30. Comorbidity 6%
31. Software 6%
32. Body Mass Index 6%
33. Thorax 5%
34. Tumor Suppressor Proteins 5%
35. Length of Stay 5%
36. Nestin 5%